Golden Biotechnology Corporation (GBC), founded by Mr. Sheng Yung, Liu in 2002, is an innovative drug discovery and herbal supplement company dedicated to enhances lives by developing high quality products that prevent and treat diseases.

GBC aimed to discover the new drugs especially in anti-cancer and anti-atherosclerosis from the screening platforms during 2002 - 2004. GBC continuously develops its pipeline of new drugs and is currently expanding into new drug development.

Antroquinonol® has applied for compound and use patents worldwide. Antroquinonol® was approved by USFDA in January and TFDA in April of 2010 for IND. Because of the great performance in efficacy and non-systemic toxicity that appeared in cancer treatment that we had in Taiwan, GDAC currently has been exported to China, Singapore, Malaysia and Japan......

Read More


AntroQ Biotechnology Sdn Bhd(105091-W)
Unit 13A, Level 2,
IOI Boulevard, Jalan Kenari 4, Bandar Puchong Jaya,
47100, Selangor Darul Ehsan, Malaysia.

(Tel) 603-8074 7008
(Fax) 603-8074 9008
Email : This email address is being protected from spambots. You need JavaScript enabled to view it.


Latest News


Golden Biotechnology Corporation, a company developing a new drug for cancer, announced that it has been granted the Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) Office of Orphan Products Development for Antroquinonol, the company's lead drug candidate



Golden Biotech has established a fermentation databank. We have signed an exclusive deal with major academic institutions in Taiwan to obtain fungus strains. Currently, 4000 fungus strains have been screened and stored in our databank. Screening is done in parallel with testing and data collection of all the fungus strains.....

Facebook Like Box